Filters
Also try searching for:
*ONZ
on 13 Jul 2022
GLAXO GROUP LIMITED
2018494 · 19 Feb 2020
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment of viral conditions namely human immunodeficiency virus (HIV), HPV, RSV, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone, androgen and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely, acid reflux and gastroesophageal reflux disease; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor and menopausal symptoms, endometriosis and uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy; Vaccines for human use.
Pharmaceutical preparations for use as anti-infectives; pharmaceutical...
on 07 Feb 2018
BIOMIN HOLDING GMBH
1599531 · 24 Oct 2012
001
Class 001
Chemical Products
005
Class 005
Pharmaceutical Products
...
Class 031
Natural Agricultural Products
Enzymes for transformation and detoxification of mycotoxins for animal food industry and industry for additives to animal foodstuff, enzymes for detoxification of mycotoxins in the industrial treatment of animal foodstuff or animal foodstuff components; veterinary preparations for prevention and treatment of mycotoxicosis, additives to fodder and drinking water for veterinary preparations for prevention and treatment of mycotoxicosis, disinfectants, antiparasitic preparations, vitamin and mineral preparations, fungicides, bacterial preparations for veterinary use for prevention and treatment of mycotoxicosis, pesticides, vermin destroying preparations, anticryptogamic preparations, insecticides, germicides, cultures of microorganisms for veterinarial use for prevention and treatment of mycotoxicosis, enzyme preparations for prevention and treatment of mycotoxicosis; animal foodstuff, additives to fodder and drinking water (not for medical purposes), mineral feed additives, meal for animals, distillery waste for animal consumption, yeast for animals, draff, animal fattening preparations, stall food for animals, proteins for animal consumption, enzyme preparations, namely enzymes for stimulating appetite, enzymes for increasing the bioavailability of nutrients, foodstuff containing proteins.
Enzymes for transformation and detoxification of mycotoxins for animal...
on 26 Feb 2013
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1520953 · 25 Mar 2011
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of cancer.
Pharmaceutical preparations for human use for the treatment and preven...
on 31 Dec 1969
OUTBOARD MARINE CORPORATION
595752 · 20 Nov 1987
025
Class 025
Clothing Products
Wearing apparel, namely shirts, sweaters, tank tops, bandeau, jackets, pants, shorts, sweatsuits, bathing suits, bathrobes, hats, and jumpsuits.
Wearing apparel, namely shirts, sweaters, tank tops, bandeau, jackets,...
on 25 Aug 1999
NAIRDO HOLDINGS LTD.
500349 · 16 Mar 1983
030
Class 030
Staple Food Products
Pizza with a pita bread crust.
Pizza with a pita bread crust.
on 12 Mar 1984
WALKAWAY SUPERVISIONS LTD.
312333 · 08 Apr 1968
025
Class 025
Clothing Products
Men, women and childrens' shoes.
Men, women and childrens' shoes.
Country
CA
Status
All
Registered
Pending
Abandoned
Other
Owners
American marine holdings llc a delaware limited liability company (1)
Biomin holding gmbh (1)
Glaxo group limited (1)
Nairdo holdings ltd. (1)
Outboard marine corporation (1)
Takeda pharmaceutical company limited (1)
Walkaway supervisions ltd. (1)
Categories
Class 5 (3)
Class 25 (2)
Class 1 (1)
Class 12 (1)
Class 30 (1)
Class 31 (1)
Correspondents
Borden ladner gervais llp (1)
Robic agence pi s.E.C./ robic ip agency lp (1)
Smart & biggar ip agency co. (1)
Smart & biggar lp (1)
Stikeman elliott llp (1)
Image Search
Drag and drop or upload to search any image
End of search results
Page 1 of 1